A ROLE FOR INTESTINAL STEAROYL-COA DESATURASES IN MODULATING COLONIC HEALTH AND SYSTEMIC ENERGY BALANCE.

Stearoyl-CoA desaturase (SCD) is an ER-resident delta-9 desaturase, responsible for the conversion of saturated fatty acids (SFAs) to monounsaturated fatty acids (MUFAs). The mouse expresses four isoforms, including SCD1, ubiquitously expressed and highest in liver and adipose tissues, and SCD2, high in the brain, but also present in adipocytes, lungs and kidneys. Previous studies have explored the role of whole body and tissue-specific SCD1 and SCD2 in modulating systemic energy metabolism. In the small intestine, deletion of SCD1 leads to reduction of intestinal and plasma lipids, and protection against diet-induced obesity. Concomitantly, mice lacking intestinal SCD2 do not confer similar phenotypes, due to upregulation of MUFA uptake in the intestines. However, no studies have been done looking at the effects of concomitant intestinal SCD1 and SCD2 deletion on local and systemic metabolism. Chapter 2 of this thesis focuses on the role of SCD1 and 2 and its MUFA products on colonic inflammation. Following generation of mice lacking intestinal SCD1 and SCD2, dKO mice, these animals displayed spontaneous appearance of rectal prolapse and had increased fecal LCN2, indicative of colonic inflammation. Using a model of chemically induced colitis, these mice were given 3% dextran sulfate sodium (DSS) in drinking water for 5 days and initiation of colitis was monitored. dKO mice were more susceptible to DSS colitis, shown by greater body weight loss and earlier appearance of blood through DSS treatment, and increased inflammatory cytokines in their colons, compared to flox mice. Colon lipidomics revealed that dKO mice had a significant reduction in MUFA-phospholipids (PLs) and a concomitant increase in polyunsaturated fatty acid (PUFA)-phospholipids, compared to flox mice. These changes led to a ferroptosis favorable state in dKO colons, as seen by significant increased PUFA-PL synthesis gene Lpcat3, reduction in MUFA-PL synthesis genes Acsl3 and Mboat1, and increase in cystine transporter SLC7A11 in dKOs compared to flox colons. dKO colons also show a strong downregulation of β-oxidation, potentially as a compensatory mechanism to limit ROS production, leading to increased colonic inflammation. Colonic lipidomics and susceptibility to colitis were reversed by dietary MUFA supplementation, highlighting the need for MUFAs to maintain colonic health. MUFAs can be synthesized endogenously, including in the liver. However, in the DSS-colitis model, previous studies have shown that SCD1 is strongly inhibited, potentially limiting availability of MUFA-lipids for other tissues. The mechanism and consequences of hepatic SCD1 downregulation following DSS treatment were studied in Chapter 3. Wild type mice were given water or water supplemented with 3% DSS for 5 days prior to tissue collection. Downregulation of hepatic SCD1 following DSS treatment was not accompanied by changes to other lipogenic genes in the liver, occurred independently of Srebp1c and was not mediated by the microbiome. In contrast, adipose tissue demonstrated coordinated reductions in lipogenic genes, including SCD1 and SCD2, while the colon did not display any perturbation of these targets. Concomitant with downregulation of hepatic SCD1, DSS treatment was associated with significant remodeling of the hepatic lipidome, including reductions in total phospholipids (PLs) and reduced MUFA-containing PLs and triacyglycerols (TAGs). Interestingly, hepatic cholesterol esters and plasma lipids, including free cholesterol and glycerophospholipids, were significantly elevated following DSS treatment. Given the significant reduction in hepatic SCD1 following DSS treatment, we tested a role for liver SCD1 in modulating colitis sensitivity. Mice with a targeted deletion of hepatic SCD1 were not more prone to DSS-colitis, indicating that the loss of hepatic SCD1, while a consequence of DSS-induced colitis, does not mediate colitis sensitivity in vivo. Chapter 2 of this thesis highlights the role for intestinal SCD in modulating colonic health, however, previous studies have demonstrated that deletion of intestinal SCD can also affect systemic metabolism and energy balance. Intestinal SCD1 knockout mice have shown protection against diet induced obesity, and Chapter 4 of this thesis explores whether deletion of intestinal SCD1 and SCD2 confers a similar phenotype. dKO mice and flox littermates were maintained on a chow diet or challenged with a 45% fat diet for 12 weeks. Intestinal morphology and lipid metabolism as well as metabolic phenotype were monitored. On chow diet, dKOs tended to be smaller and both males and females showed increased energy expenditure compared to flox mice. Male dKOs also displayed improvement of glucose handling on chow diet. Following high fat diet, dKO males had reduced body weight gain early in the study, remained lighter than flox mice, and showed increased energy expenditure. Female dKOs did not show a difference in body weights or energy expenditure with flox females. Paradoxically, both male and female dKOs on high fat diet had worsened glucose clearance, despite resistance to HFD-induced adiposity and weight gain in males. Together, these data suggest a role for intestinal desaturases in modulating energy sensing and systemic metabolism.

Authors

Publication Details

Journal
Rutgers University Community Repository (Rutgers University)
Published
2026-11-17
DOI
https://doi.org/10.7282/t3-j6yr-5648
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A ROLE FOR INTESTINAL STEAROYL-COA DESATURASES IN MODULATING COLONIC HEALTH AND SYSTEMIC ENERGY BALANCE.

Camille Duchamp
1 links
Rutgers University Community Repository (Rutgers University)
Gut microbiota and health
article

A ROLE FOR INTESTINAL STEAROYL-COA DESATURASES IN MODULATING COLONIC HEALTH AND SYSTEMIC ENERGY BALANCE.

Camille Duchamp
article en

Abstract

Stearoyl-CoA desaturase (SCD) is an ER-resident delta-9 desaturase, responsible for the conversion of saturated fatty acids (SFAs) to monounsaturated fatty acids (MUFAs). The mouse expresses four isoforms, including SCD1, ubiquitously expressed and highest in liver and adipose tissues, and SCD2, high in the brain, but also present in adipocytes, lungs and kidneys. Previous studies have explored the role of whole body and tissue-specific SCD1 and SCD2 in modulating systemic energy metabolism. In the small intestine, deletion of SCD1 leads to reduction of intestinal and plasma lipids, and protection against diet-induced obesity. Concomitantly, mice lacking intestinal SCD2 do not confer similar phenotypes, due to upregulation of MUFA uptake in the intestines. However, no studies have been done looking at the effects of concomitant intestinal SCD1 and SCD2 deletion on local and systemic metabolism. Chapter 2 of this thesis focuses on the role of SCD1 and 2 and its MUFA products on colonic inflammation. Following generation of mice lacking intestinal SCD1 and SCD2, dKO mice, these animals displayed spontaneous appearance of rectal prolapse and had increased fecal LCN2, indicative of colonic inflammation. Using a model of chemically induced colitis, these mice were given 3% dextran sulfate sodium (DSS) in drinking water for 5 days and initiation of colitis was monitored. dKO mice were more susceptible to DSS colitis, shown by greater body weight loss and earlier appearance of blood through DSS treatment, and increased inflammatory cytokines in their colons, compared to flox mice. Colon lipidomics revealed that dKO mice had a significant reduction in MUFA-phospholipids (PLs) and a concomitant increase in polyunsaturated fatty acid (PUFA)-phospholipids, compared to flox mice. These changes led to a ferroptosis favorable state in dKO colons, as seen by significant increased PUFA-PL synthesis gene Lpcat3, reduction in MUFA-PL synthesis genes Acsl3 and Mboat1, and increase in cystine transporter SLC7A11 in dKOs compared to flox colons. dKO colons also show a strong downregulation of β-oxidation, potentially as a compensatory mechanism to limit ROS production, leading to increased colonic inflammation. Colonic lipidomics and susceptibility to colitis were reversed by dietary MUFA supplementation, highlighting the need for MUFAs to maintain colonic health. MUFAs can be synthesized endogenously, including in the liver. However, in the DSS-colitis model, previous studies have shown that SCD1 is strongly inhibited, potentially limiting availability of MUFA-lipids for other tissues. The mechanism and consequences of hepatic SCD1 downregulation following DSS treatment were studied in Chapter 3. Wild type mice were given water or water supplemented with 3% DSS for 5 days prior to tissue collection. Downregulation of hepatic SCD1 following DSS treatment was not accompanied by changes to other lipogenic genes in the liver, occurred independently of Srebp1c and was not mediated by the microbiome. In contrast, adipose tissue demonstrated coordinated reductions in lipogenic genes, including SCD1 and SCD2, while the colon did not display any perturbation of these targets. Concomitant with downregulation of hepatic SCD1, DSS treatment was associated with significant remodeling of the hepatic lipidome, including reductions in total phospholipids (PLs) and reduced MUFA-containing PLs and triacyglycerols (TAGs). Interestingly, hepatic cholesterol esters and plasma lipids, including free cholesterol and glycerophospholipids, were significantly elevated following DSS treatment. Given the significant reduction in hepatic SCD1 following DSS treatment, we tested a role for liver SCD1 in modulating colitis sensitivity. Mice with a targeted deletion of hepatic SCD1 were not more prone to DSS-colitis, indicating that the loss of hepatic SCD1, while a consequence of DSS-induced colitis, does not mediate colitis sensitivity in vivo. Chapter 2 of this thesis highlights the role for intestinal SCD in modulating colonic health, however, previous studies have demonstrated that deletion of intestinal SCD can also affect systemic metabolism and energy balance. Intestinal SCD1 knockout mice have shown protection against diet induced obesity, and Chapter 4 of this thesis explores whether deletion of intestinal SCD1 and SCD2 confers a similar phenotype. dKO mice and flox littermates were maintained on a chow diet or challenged with a 45% fat diet for 12 weeks. Intestinal morphology and lipid metabolism as well as metabolic phenotype were monitored. On chow diet, dKOs tended to be smaller and both males and females showed increased energy expenditure compared to flox mice. Male dKOs also displayed improvement of glucose handling on chow diet. Following high fat diet, dKO males had reduced body weight gain early in the study, remained lighter than flox mice, and showed increased energy expenditure. Female dKOs did not show a difference in body weights or energy expenditure with flox females. Paradoxically, both male and female dKOs on high fat diet had worsened glucose clearance, despite resistance to HFD-induced adiposity and weight gain in males. Together, these data suggest a role for intestinal desaturases in modulating energy sensing and systemic metabolism.

Rutgers University Community Repository (Rutgers University)
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon